Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
IDXX Idexx Laboratories Inc
- Stocks
- Healthcare
- NASDAQ: IDXX
Price (delayed)
$524.15
Market cap
$42.15B
P/E Ratio
48
Dividend/share
N/A
EPS
$10.92
Enterprise value
$43.03B
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and
Highlights
The gross profit has increased by 8% YoY
IDXX's revenue is up by 6% year-on-year
IDXX's price to earnings (P/E) is 14% lower than its 5-year quarterly average of 55.9 but 11% higher than its last 4 quarters average of 43.2
The quick ratio has decreased by 36% YoY and by 14% QoQ
The company's equity fell by 9% QoQ and by 8% YoY
Key stats
What are the main financial stats of IDXX
Market
Valuations
Earnings
Shares outstanding
80.42M
Market cap
$42.15B
Enterprise value
$43.03B
Price to earnings (P/E)
48
Price to book (P/B)
29.44
Price to sales (P/S)
10.84
EV/EBIT
37.24
EV/EBITDA
33.37
EV/Sales
10.94
Revenue
$3.93B
Gross profit
$2.41B
Operating income
$1.15B
Net income
$894.97M
EBIT
$1.16B
EBITDA
$1.29B
Free cash flow
$837.7M
Per share
Balance sheet
Liquidity
EPS
$10.92
EPS diluted
$10.82
Free cash flow per share
$10.3
Book value per share
$17.8
Revenue per share
$48.35
TBVPS
$33.19
Total assets
$3.21B
Total liabilities
$1.77B
Debt
$1.04B
Equity
$1.45B
Working capital
$181.4M
Debt to equity
0.72
Current ratio
1.16
Quick ratio
0.61
Net debt/EBITDA
0.68
Margins
Efficiency
Dividend
EBITDA margin
32.8%
Gross margin
61.3%
Net margin
22.8%
Operating margin
29.1%
Return on assets
27%
Return on equity
57.4%
Return on invested capital
47.5%
Return on capital employed
55.6%
Return on sales
29.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IDXX stock price
How has the Idexx Laboratories stock price performed over time
Intraday
0.37%
1 week
2.1%
1 month
10.65%
1 year
5.28%
YTD
26.78%
QTD
24.81%
Financial performance
How have Idexx Laboratories's revenue and profit performed over time
Revenue
$3.93B
Gross profit
$2.41B
Operating income
$1.15B
Net income
$894.97M
Gross margin
61.3%
Net margin
22.8%
The gross profit has increased by 8% YoY
IDXX's revenue is up by 6% year-on-year
IDXX's operating margin is down by 3% YoY
The company's net income rose by 3.3% YoY
Price vs fundamentals
How does IDXX's price correlate with its fundamentals
Growth
What is Idexx Laboratories's growth rate over time
Valuation
What is Idexx Laboratories stock price valuation
P/E
48
P/B
29.44
P/S
10.84
EV/EBIT
37.24
EV/EBITDA
33.37
EV/Sales
10.94
IDXX's price to earnings (P/E) is 14% lower than its 5-year quarterly average of 55.9 but 11% higher than its last 4 quarters average of 43.2
The company's EPS rose by 4.7% YoY
The price to book (P/B) is 44% less than the 5-year quarterly average of 52.4 but 22% more than the last 4 quarters average of 24.0
The company's equity fell by 9% QoQ and by 8% YoY
The P/S is 12% below the 5-year quarterly average of 12.3 but 11% above the last 4 quarters average of 9.7
IDXX's revenue is up by 6% year-on-year
Efficiency
How efficient is Idexx Laboratories business performance
Idexx Laboratories's return on equity has decreased by 10% YoY but it has increased by 2.9% QoQ
Idexx Laboratories's return on invested capital has increased by 5% YoY and by 2.4% QoQ
The company's return on sales fell by 2.6% YoY
The return on assets has declined by 2.2% year-on-year
Dividends
What is IDXX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IDXX.
Financial health
How did Idexx Laboratories financials performed over time
The company's total assets is 82% higher than its total liabilities
The quick ratio has decreased by 36% YoY and by 14% QoQ
IDXX's current ratio is down by 26% year-on-year and by 11% since the previous quarter
The debt is 28% less than the equity
IDXX's debt to equity is up by 18% QoQ and by 7% YoY
The company's equity fell by 9% QoQ and by 8% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.